Finance

Lists
Why is EVFM down 6,67%?
Dive Deeper
EVFM:OTCMKTS
Evofem Biosciences Inc
0,0070 US$
-6,67%
(-0,00050) 1D
13 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVFM...
Open
0,01 US$
High
0,01 US$
Low
0,01 US$
Mkt. cap
695,79 ათ.
Avg. vol.
113,64 ათ.
Volume
34,28 ათ.
52-wk high
0,02 US$
52-wk low
0,00 US$
EPS
-0,14 US$
Beta
-1,37
Shares outstanding
132,53 მლნ.
No. of employees
29
Open
0,01 US$
High
0,01 US$
Low
0,01 US$
Mkt. cap
695,79 ათ.
Avg. vol.
113,64 ათ.
Volume
34,28 ათ.
52-wk high
0,02 US$
52-wk low
0,00 US$
EPS
-0,14 US$
Beta
-1,37
Shares outstanding
132,53 მლნ.
No. of employees
29
News stories
From web sources and news partners
About Evofem Biosciences Inc
CEOსანდრა პელეტიე
Employees29
Founded2007
Headquarters-
SectorPharmaceutical industry
Websiteevofem.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
4,95 მლნ.
9,56 მლნ.
899,00 ათ.
2,63 მლნ.
Cost of goods sold
905,00 ათ.
2,59 მლნ.
410,00 ათ.
511,00 ათ.
Cost of revenue
905,00 ათ.
2,59 მლნ.
410,00 ათ.
511,00 ათ.
Research and development expenses
469,00 ათ.
372,00 ათ.
517,00 ათ.
693,00 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,48 მლნ.
3,16 მლნ.
4,47 მლნ.
3,90 მლნ.
Operating expense
5,03 მლნ.
3,62 მლნ.
5,06 მლნ.
4,61 მლნ.
Total operating expenses
5,93 მლნ.
6,22 მლნ.
5,47 მლნ.
5,12 მლნ.
Operating income
-982,00 ათ.
3,34 მლნ.
-4,57 მლნ.
-2,49 მლნ.
Other non operating income
-2,53 მლნ.
2,08 მლნ.
-162,00 ათ.
-5,76 მლნ.
EBT including unusual items
-1,57 მლნ.
2,79 მლნ.
-5,47 მლნ.
-11,04 მლნ.
EBT excluding unusual items
-3,51 მლნ.
2,79 მლნ.
-5,47 მლნ.
-8,84 მლნ.
Income tax expense
-4,00 ათ.
-1,00 ათ.
-1,00 ათ.
-
Effective tax rate
0,25%
-0,04%
0,02%
-
Other operating expenses
-
-
-
-
Net income
-1,57 მლნ.
2,79 მლნ.
-5,46 მლნ.
-11,04 მლნ.
Net profit margin
-31,68%
29,16%
-607,90%
-419,14%
Earnings per share
-
-
-
-
Interest and investment income
3,00 ათ.
2,00 ათ.
2,00 ათ.
3,00 ათ.
Interest expense
-
-2,64 მლნ.
-737,00 ათ.
-600,00 ათ.
Net interest expenses
3,00 ათ.
-2,63 მლნ.
-735,00 ათ.
-597,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-898,00 ათ.
3,44 მლნ.
-4,49 მლნ.
-2,47 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები